These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1297 related items for PubMed ID: 9005168

  • 1. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A.
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [Abstract] [Full Text] [Related]

  • 2. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T, Pacher R, Wimmer A, Bojic A, Hülsmann M, Frey B, Mayer G, Yilmaz N, Skvarilova L, Spinar J, Vitovec J, Toman J, Woloszcuk W, Stanek B.
    Wien Klin Wochenschr; 1998 Feb 13; 110(3):89-95. PubMed ID: 9553203
    [Abstract] [Full Text] [Related]

  • 3. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Feb 13; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 4. [The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure].
    Indolfi C, Piscione F, Volpe M, Lembo G, De Campora P, Russolillo E, Ambrosini V, Condorelli M, Chiariello M.
    Cardiologia; 1991 May 13; 36(5):351-6. PubMed ID: 1836751
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic correlates of atrial natriuretic peptide concentration in unselected patients with heart disease of different etiologies.
    La Vecchia L, Fortunato A, Varotto L, Bonanno C, Paccanaro M, Ometto R, Vincenzi M.
    G Ital Cardiol; 1998 Dec 13; 28(12):1363-71. PubMed ID: 9887389
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M, Stanek B, Frey B, Berger R, Rödler S, Siegel A, Hartter E, Schuller M, Ogris E, Pacher R.
    J Heart Lung Transplant; 1997 May 13; 16(5):556-62. PubMed ID: 9171275
    [Abstract] [Full Text] [Related]

  • 7. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 13; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS, Gottlieb SS, Singh BN, Ramanathan KB, Ogilby JD, Ellenbogen KA.
    J Am Coll Cardiol; 1995 Dec 13; 26(7):1679-84. PubMed ID: 7594103
    [Abstract] [Full Text] [Related]

  • 12. [The concentration of atrial natriuretic peptides (ANP). ANP in different sections of the circulation during atrial volume load with and without anesthesia].
    Günnicker M, Freund U, Karzai W, Benker G, Hirche H, Hess W.
    Anaesthesist; 1992 Dec 13; 41(12):745-51. PubMed ID: 1489072
    [Abstract] [Full Text] [Related]

  • 13. Early and medium term results of tailored therapy for heart failure.
    Martins S, Soares RM, do Rosário L, Quininha J, Antunes AM.
    Rev Port Cardiol; 2001 Mar 13; 20(3):261-82. PubMed ID: 11417309
    [Abstract] [Full Text] [Related]

  • 14. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN, Tsagalou EP, Nanas SN, Terrovitis JV, Tsolakis EJ, Toumanidis S, Papazoglou PD, Alexopoulos GP, Kanakakis J, Anastasiou-Nana MI.
    Int J Cardiol; 2006 Apr 04; 108(2):237-43. PubMed ID: 16183152
    [Abstract] [Full Text] [Related]

  • 15. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure.
    Wozakowska-Kapłon B, Opolski G, Janion M, Kosior D.
    Kardiol Pol; 2004 Dec 04; 61(12):513-21; discussion 522. PubMed ID: 15815752
    [Abstract] [Full Text] [Related]

  • 16. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 04; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 17. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
    Stangl K, Baumann G, Weil J, Gerzer R, Kerscher M, Blömer H.
    Z Kardiol; 1990 Jun 04; 79(6):417-23. PubMed ID: 1974099
    [Abstract] [Full Text] [Related]

  • 18. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R.
    Rev Esp Cardiol; 1994 Oct 04; 47(10):682-6. PubMed ID: 7991922
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.